SCHEMBL8146178

SCHEMBL8146178

O=C(O)[C@H](CCc1ccccc1)NS(=O)(=O)c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.63
CYP1A2 P05177 1/20 0.63
CYP2C9 P11712 1/20 0.63
CYP2C19 P33261 1/20 0.63
MMP2 P08253 13/20 0.63
MMP9 P14780 12/20 0.63
MMP8 P22894 3/20 0.63
MMP12 P39900 2/20 0.63
MMP14 P50281 2/20 0.63
ADAMTS4 O75173 2/20 0.62
MMP7 P09237 1/20 0.62
MMP13 P45452 1/20 0.61
ITGB3 P05106 1/20 0.56
ITGA2B P08514 1/20 0.56
ADAMTS5 Q9UNA0 1/20 0.56
MAPT P10636 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8707457 1.00 ALDH1A1 (0.63) ALDH1A1CYP1A2CYP2C9CYP2C19MMP2
SCHEMBL8146180 1.00 ALDH1A1 (0.63) ALDH1A1CYP1A2CYP2C9CYP2C19MMP2
SCHEMBL8839562 0.90 MMP2 (0.70) ALDH1A1MMP2MMP9MMP8MMP12
SCHEMBL8839772 0.90 MMP2 (0.70) MMP2MMP9MMP8MMP12MMP14
SCHEMBL8839774 0.90 MMP2 (0.70) MMP2MMP9MMP8MMP12MMP14
SCHEMBL8839555 0.90 MMP2 (0.70) ALDH1A1MMP2MMP9MMP8MMP12
SCHEMBL14602243 0.87 MMP2 (0.77) MMP2MMP9MMP8MMP12MMP14
SCHEMBL7300504 0.85 MMP7 (0.64) MMP2MMP9MMP8MMP12MMP14
SCHEMBL7906607 0.84 MMP9 (0.78) MMP2MMP9MMP8MMP12MMP14
SCHEMBL697591 0.84 MMP2 (0.85) ALDH1A1MMP2MMP9ADAMTS4MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6030946-A FUNCTIONS REVERSIBLY, RESULTING IN TIGHT BINDING (LOW DISSOCIATION CONSTANTS) BETWEEN INHIBITOR AND TARGET ENZYME; USED TO TREAT VARIETY OF DISEAES, INCLUDING ARTHRITIS, MUSCULAR DYSTROPHY, INFLAMMATION, TUMOR INVASION, MALERIA AXYS PHARMACEUTICALS, INC. (US) 2000-02-29 US disclosed
EP-0832099-A1 REVERSIBLE CYSTEINE PROTEASE INHIBITORS ARRIS PHARMACEUTICAL CORPORATION (US) 1998-04-01 EP disclosed
WO-1996040737-A1 REVERSIBLE CYSTEINE PROTEASE INHIBITORS ARRIS PHARMACEUTICAL CORPORATION (US) 1996-12-19 WO disclosed